eversyn is a spin-off of the Max Planck Institute Magdeburg - run, founded and supported by current and former Max Planck scientists and business professionals. Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Universitätsplatz 2, Ovgu - Building 25,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.eversyn.de/
- Keywords
- Synthetic Glycobiotechnology, Glycobiotechnology, Biotechnology, Oligosaccharides, Nucleotide Sugars, In Vitro Glycoengineering, HMOs, activated sugars.
- HQ
- Magdeburg, Saxony-Anhalt
Eversyn Gmbh Questions
Eversyn Gmbh's website is https://www.eversyn.de/
Eversyn Gmbh's LinkedIn profile is https://de.linkedin.com/company/eversyn
Eversyn Gmbh has
7 employees.
View email and phone details for 7
employees at Eversyn Gmbh.
Eversyn Gmbh's industry is
Biotechnology Research
Eversyn Gmbh's top competitors are
Red Cable Robots,
Max Planck Institute For Dynamics Of Complex Technical Systems,
Esencia Foods,
Histolution Gmbh,
Lucid Genomics,
Start2 Group,
Niostem,
Nutropy,
Maity,
Ester Biotech Gmbh.
Eversyn Gmbh's categories are Biotechnology Research
Eversyn Gmbh's founding year is 2022
